ProShares UltraShort Health Care
RXD
1 hedge funds and large institutions have $25K invested in ProShares UltraShort Health Care in 2018 Q3 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 1 closing their positions.
11% less call options, than puts
Call options by funds: $25M | Put options by funds: $28.1M
39.6% less ownership
Funds ownership: 42.51% → 2.9% (-40%)
50% less funds holding
Funds holding: 2 → 1 (-1)
98% less capital inflows, than outflows
Capital inflows: $7.7K | Capital outflows: $452K
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$7.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$452K |
RXD Hedge Fund Activity: Q3 2018 in Review
1 of the 4,392 institutional investors tracked by Wall St. Rank reported a position in ProShares UltraShort Health Care (RXD) for Q3 2018, worth a combined $25K — down 95% from $475K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of RXD and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 1 added.
The largest buyer was UBS Group, adding an estimated $7.7K. The largest seller was Susquehanna International Group, exiting entirely with an estimated $452K sold.
- 1 institutional investor held ProShares UltraShort Health Care (RXD) as of Q3 2018, down from 2 in Q2 2018.
- Funds reported $25K of ProShares UltraShort Health Care stock for Q3 2018, down 95% quarter-over-quarter.
- 0 funds opened new ProShares UltraShort Health Care positions in Q3 2018 and 1 closed out, a net change of -1 holder.
- The largest ProShares UltraShort Health Care buyer in Q3 2018 was UBS Group, an estimated $7.7K added.
- The largest ProShares UltraShort Health Care seller in Q3 2018 was Susquehanna International Group, an estimated $452K sold.
Based on aggregated 13F filings for Q3 2018.